Cargando…
Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania
Preclinical evidence suggests that antidepressants (ADs) may differentially influence mitochondrial energetics. This study was conducted to investigate the relationship between mitochondrial function and illness vulnerability in bipolar disorder (BD), specifically risk of treatment-emergent mania (T...
Autores principales: | Gardea-Resendez, Manuel, Coombes, Brandon J., Veldic, Marin, Tye, Susannah J., Romo-Nava, Francisco, Ozerdem, Aysegul, Prieto, Miguel L., Cuellar-Barboza, Alfredo, Nunez, Nicolas A., Singh, Balwinder, Pendegraft, Richard S., Miola, Alessandro, McElroy, Susan L., Biernacka, Joanna M., Morava, Eva, Kozicz, Tamas, Frye, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005962/ https://www.ncbi.nlm.nih.gov/pubmed/36513812 http://dx.doi.org/10.1038/s41380-022-01888-x |
Ejemplares similares
-
Antidepressant-Associated Treatment Emergent Mania: A Meta-Analysis to Guide Risk Modeling Pharmacogenomic Targets of Potential Clinical Value
por: Nuñez, Nicolas A., et al.
Publicado: (2023) -
Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder
por: Nunez, Nicolas A., et al.
Publicado: (2022) -
Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study
por: Joseph, Boney, et al.
Publicado: (2023) -
Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study
por: Gardea-Resendez, Manuel, et al.
Publicado: (2023) -
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
por: Cuéllar-Barboza, Alfredo B., et al.
Publicado: (2020)